Onegene biotechnology is developing multi-target medications for treatment of complex and chronic diseases through the protein combination platform ‘UniStac’ technology based on independently developed albumin. Major pipelines consist of development of non-alcoholic steatohepatitis (NASH) medication, cancer immunotherapy, etc.
Investors 4
| Date | Name | Website |
| - | SV Investm... | svinvest.c... |
| 21.12.2020 | Quantum Ve... | quantumepk... |
| - | UTC Invest... | utc.co.kr |
| 20.06.2023 | Premier Pa... | premierpar... |